Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Cytokines

Recombinant Mouse PF4/CXCL4 Protein, N-His-SUMO

Catalog #:   YMC01801 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q9Z126
Protein length: His55-Ser105
Overview

Catalog No.

YMC01801

Expression system

E. coli

Species

Mus musculus (Mouse)

Protein length

His55-Ser105

Predicted molecular weight

18.12 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q9Z126

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

C-X-C motif chemokine 4, PF-4, Oncostatin-A, Endothelial cell growth inhibitor, CXCL4, Iroplact, Platelet factor 4, PF4, SCYB4

Data Image
  • SDS-PAGE
    SDS-PAGE for Recombinant Mouse PF4/CXCL4 protein
References

Insights into platelet factor 4-derived peptide macrocycles; the mechanistic basis of their rapid and selective antiplasmodial actions., PMID:40490548

The potential role of biomarkers CD28 and PF4 in the pathogenesis of idiopathic pulmonary fibrosis and their impact on the prognosis: an immune microenvironment analysis., PMID:40483519

Investigation into the binding domains of platelet factor 4 unlocks new avenues for the design and synthesis of selective sulfated pseudo-tetrasaccharide aminoglycoside ligands., PMID:40424780

Enhanced wound healing function of fibronectin variants via fusing with platelet factor 4., PMID:40373928

Classification of Platelet-Activating Anti-Platelet Factor 4 Disorders., PMID:40358013

Endoplasmic reticulum protein 29 negatively regulates platelet functions and thrombosis in mice., PMID:40336049

Longitudinal assessment of immunogenicity of inactivated COVID-19 booster immunization and breakthrough infection in blood donors: A multicenter study from 2021 to 2023., PMID:40323225

Case Report: Anti-platelet factor 4 -mediated immunothrombosis in a patient with ANCA vasculitis - a shared mechanism of NETosis., PMID:40276517

Antiplatelet-anticoagulant, APAC, a mimic of endogenous heparin, is an antithrombotic with von Willebrand factor-mediated characteristics., PMID:40252546

Integrative In-Silico Analysis of Retroperitoneal Tumors in Colorectal Surgery: Advancements and Implications., PMID:40238057

PF4 promotes CXCR3+ Tfh1 cell differentiation through STAT1 in mouse immune thrombocytopenia., PMID:40235276

Refractory delayed-onset heparin induced thrombocytopenia (HIT) without thrombosis, treated with intravenous immunoglobulin., PMID:40233637

PF4-dependent P-selectin expression assay in comparison to the heparin-induced platelet activation assay for the diagnosis of heparin-induced thrombocytopenia., PMID:40191970

Prospective multicenter comparison of the diagnostic value of IgG and IgGAM antibodies for heparin-induced thrombocytopenia., PMID:40187717

Refractory autoimmune heparin-induced thrombocytopenia following cardiac surgery., PMID:40158808

Platelet activation and COPD-related clinical and imaging characteristics: The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study., PMID:40147570

The Role of CXCL4 in Systemic Sclerosis: DAMP, Auto-Antigen and Biomarker., PMID:40141068

Heterogeneity and longitudinal transcriptomic characteristics of Tregs in COVID-19 patients., PMID:40114921

Lienal Polypeptide Decreases Immune Thrombocytopenia in a Mouse Model by Upregulating Cytokine Production and Increasing the Levels of CD4+, CD8+, and T Regulatory Cells., PMID:40113259

Platelet-activating cytokines potentially associated with MASLD-induced liver injury significantly decreased following CPAP therapy: A translational study using a fatty liver mouse model., PMID:40112616

Endothelial cell activation enhances thromboinflammation in vaccine-induced immune thrombotic thrombocytopenia., PMID:40085945

Platelet activation stimulates macrophages to enhance ulcerative colitis through PF4/CXCR3 signaling., PMID:40084691

Involvement of disulfidptosis in the pathophysiology of autism spectrum disorder., PMID:40054734

Beclin 1 of megakaryocytic lineage cells is locally dispensable for platelet hemostasis but functions distally in bone homeostasis., PMID:40032858

Platelet C3G protects from liver fibrosis, while enhancing tumor growth through regulation of the immune response., PMID:39989399

VITT-like Monoclonal Gammopathy of Thrombotic Significance., PMID:39938091

Structural and functional changes underlying activation of monocytes in heparin-induced thrombocytopenia., PMID:39933652

Transplantation of autologous endothelial progenitor cells promotes the repair of fusiform aneurysms., PMID:39923840

Efficacy and Safety of Recombinant Human Thrombopoietin (rhTPO) on Coagulation Function and Inflammatory Factors in the Treatment of Patients with Sepsis-Related Thrombocytopenia., PMID:39901742

Identification of disulfide bond-linking sites in biosynthesized platelet factor 4 by establishing a partial reduction method without alkylation., PMID:39865791

Inovirus-Encoded Peptides Induce Specific Toxicity in Pseudomonas aeruginosa., PMID:39861901

The Platelet-Specific Gene Signature in the Immunoglobulin G4-Related Disease Transcriptome., PMID:39859144

Decreased serum PF4 levels correlate with cognitive decline and CSF biomarkers in Alzheimer's disease in a Chinese cohort., PMID:39855320

PD-L1 positive platelets mediate resistance to immune checkpoint inhibitors in patients with colorectal cancer., PMID:39815258

α-Actinin-1 deficiency in megakaryocytes causes low platelet count, platelet dysfunction, and mitochondrial impairment., PMID:39813624

Observation on the efficacy of TPO receptor agonists and platelet transfusion in chemotherapy-induced thrombocytopenia in malignant tumors., PMID:39810144

Complex Pattern of Platelet Activation/Reactivity After SARS-CoV-2 Infection., PMID:39795908

Platelet factor 4-derived C15 peptide broadly inhibits enteroviruses by disrupting viral attachment., PMID:39772852

Complement activation as a biomarker for platelet-activating antibodies in heparin-induced thrombocytopenia., PMID:39725085

Platelet spleen tyrosine kinase is a key regulator of anti-PF4 antibody-induced immunothrombosis., PMID:39705541

Platelets as key cells in endometriosis patients: Insights from small extracellular vesicles in peritoneal fluid and endometriotic lesions analysis., PMID:39698929

PF4 Silencing Promotes Trophoblast Cell Proliferation, Migration, Invasion and EMT by Regulating SOCS3/STAT3 Signaling Pathway., PMID:39694960

Nbeal2 knockout mice are not protected against hypoxia-induced pulmonary vascular remodeling and pulmonary hypertension., PMID:39693512

Imaging flow cytometry as a novel approach for the diagnosis of heparin-induced thrombocytopenia., PMID:39658032

Effect of proanthocyanidins on cognitive improvement in thyroxin-induced aging mice., PMID:39651563

Demystifying autoimmune HIT: what it is, when to test, and how to treat., PMID:39644061

S6K/FLNC/ITGβ3 signaling pathway regulates osteoclastogenesis and the inhibition of osteoclastogenesis by columbianadin., PMID:39612888

PF4 regulates neuronal ferroptosis in cerebral hemorrhage through CXCR3/PI3K/AKT/Nrf2 pathway., PMID:39601768

Prothrombotic antibodies targeting the spike protein's receptor-binding domain in severe COVID-19., PMID:39576992

Platelet factor 4-induced TH1-Treg polarization suppresses antitumor immunity., PMID:39571033

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Mouse PF4/CXCL4 Protein, N-His-SUMO [YMC01801]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only